AGIOS PHARMACEUTICALS, INC. Investment Income, Interest
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Investment Income, Interest of $12.79 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2023-02-23
- AGIOS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2022-03-31 was $694.00K, a 104.12% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2021-03-31 was $340.00K, a 88.42% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2020-12-31 was $791.00K, a 77.90% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for the quarter ending 2020-09-30 was $1.11M, a 61.38% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for fiscal 2022 was $12.79M, a 1430.26% increase from fiscal 2021.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for fiscal 2021 was $836.00K, a 87.35% decline from fiscal 2020.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for fiscal 2020 was $6.61M, a 55.51% decline from fiscal 2019.
- AGIOS PHARMACEUTICALS, INC. investment income, interest for fiscal 2019 was $14.86M, a 9.67% decline from fiscal 2018.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | $12.79M 10-K · filed 2023-02-23 | |||
| 2022-03-31 | $694.00K 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | $836.00K 10-K · filed 2023-02-23 | |||
| 2021-03-31 | $340.00K 10-Q · filed 2022-05-05 | $1.13M derived: sum of 2 quarters · filed 2023-02-23 | $2.25M derived: sum of 3 quarters · filed 2023-02-23 | $4.01M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.91M derived: sum of 2 quarters · filed 2023-02-23 | $3.67M derived: sum of 3 quarters · filed 2023-02-23 | $6.61M 10-K · filed 2023-02-23 |
| 2020-09-30 | $1.11M 10-Q · filed 2020-11-05 | $2.88M derived: sum of 2 quarters · filed 2020-11-05 | $5.82M 10-Q · filed 2020-11-05 | $9.40M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $1.77M 10-Q · filed 2020-07-30 | $4.71M 10-Q · filed 2020-07-30 | $8.28M derived: sum of 3 quarters · filed 2022-02-24 | $11.17M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $2.94M 10-Q · filed 2021-04-29 | $6.51M derived: sum of 2 quarters · filed 2022-02-24 | $9.40M derived: sum of 3 quarters · filed 2022-02-24 | $13.39M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.47M derived: sum of 2 quarters · filed 2022-02-24 | $10.46M derived: sum of 3 quarters · filed 2022-02-24 | $14.86M 10-K · filed 2022-02-24 |
| 2019-09-30 | $2.89M 10-Q · filed 2020-11-05 | $6.88M derived: sum of 2 quarters · filed 2020-11-05 | $11.28M 10-Q · filed 2020-11-05 | $15.84M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $3.99M 10-Q · filed 2020-07-30 | $8.39M 10-Q · filed 2020-07-30 | $12.96M derived: sum of 3 quarters · filed 2021-02-25 | $17.45M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $4.41M 10-Q · filed 2020-04-30 | $8.97M derived: sum of 2 quarters · filed 2021-02-25 | $13.46M derived: sum of 3 quarters · filed 2021-02-25 | $17.67M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.06M derived: sum of 2 quarters · filed 2021-02-25 | $13.26M derived: sum of 3 quarters · filed 2021-02-25 | $16.45M 10-K · filed 2021-02-25 |
| 2018-09-30 | $4.50M 10-Q · filed 2019-10-31 | $8.70M derived: sum of 2 quarters · filed 2019-10-31 | $11.89M 10-Q · filed 2019-10-31 | $13.73M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $4.20M 10-Q · filed 2019-08-01 | $7.39M 10-Q · filed 2019-08-01 | $9.24M derived: sum of 3 quarters · filed 2020-02-19 | $11.12M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $3.19M 10-Q · filed 2019-05-02 | $5.03M derived: sum of 2 quarters · filed 2020-02-19 | $6.91M derived: sum of 3 quarters · filed 2020-02-19 | $8.43M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $3.73M derived: sum of 2 quarters · filed 2020-02-19 | $5.24M derived: sum of 3 quarters · filed 2020-02-19 | $6.12M 10-K · filed 2020-02-19 |
| 2017-09-30 | $1.88M 10-Q · filed 2018-11-01 | $3.40M derived: sum of 2 quarters · filed 2018-11-01 | $4.28M 10-Q · filed 2018-11-01 | $5.20M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $1.52M 10-Q · filed 2018-08-02 | $2.40M 10-Q · filed 2018-08-02 | $3.32M derived: sum of 3 quarters · filed 2019-02-14 | $4.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $881.00K 10-Q · filed 2018-05-04 | $1.80M derived: sum of 2 quarters · filed 2019-02-14 | $2.48M derived: sum of 3 quarters · filed 2019-02-14 | $3.00M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $1.60M derived: sum of 2 quarters · filed 2019-02-14 | $2.12M derived: sum of 3 quarters · filed 2019-02-14 | $2.51M 10-K · filed 2019-02-14 |
| 2016-09-30 | $678.00K 10-Q · filed 2017-11-01 | $1.20M derived: sum of 2 quarters · filed 2017-11-01 | $1.59M 10-Q · filed 2017-11-01 | $1.87M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-06-30 | $517.00K 10-Q · filed 2017-08-08 | $913.00K 10-Q · filed 2017-08-08 | $1.19M derived: sum of 3 quarters · filed 2018-02-14 | $1.41M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-03-31 | $396.00K 10-Q · filed 2017-05-04 | $672.00K derived: sum of 2 quarters · filed 2018-02-14 | $890.00K derived: sum of 3 quarters · filed 2018-02-14 | $1.13M derived: sum of 4 quarters · filed 2018-02-14 |
| 2015-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $494.00K derived: sum of 2 quarters · filed 2018-02-14 | $730.00K derived: sum of 3 quarters · filed 2018-02-14 | $968.00K 10-K · filed 2018-02-14 |
| 2015-09-30 | $218.00K 10-Q · filed 2016-11-03 | $454.00K derived: sum of 2 quarters · filed 2016-11-03 | $692.00K 10-Q · filed 2016-11-03 | $777.00K derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | $236.00K 10-Q · filed 2016-08-08 | $474.00K 10-Q · filed 2016-08-08 | $559.00K derived: sum of 3 quarters · filed 2017-02-16 | $607.00K derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | $238.00K 10-Q · filed 2016-05-09 | $323.00K derived: sum of 2 quarters · filed 2017-02-16 | $371.00K derived: sum of 3 quarters · filed 2017-02-16 | $405.00K derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $133.00K derived: sum of 2 quarters · filed 2017-02-16 | $167.00K derived: sum of 3 quarters · filed 2017-02-16 | $203.00K 10-K · filed 2017-02-16 |
| 2014-09-30 | $48.00K 10-Q · filed 2015-11-06 | $82.00K derived: sum of 2 quarters · filed 2015-11-06 | $118.00K 10-Q · filed 2015-11-06 | $147.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $34.00K 10-Q · filed 2015-08-07 | $70.00K 10-Q · filed 2015-08-07 | $99.00K derived: sum of 3 quarters · filed 2016-02-26 | $112.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $36.00K 10-Q · filed 2015-05-11 | $65.00K derived: sum of 2 quarters · filed 2016-02-26 | $78.00K derived: sum of 3 quarters · filed 2016-02-26 | $83.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $42.00K derived: sum of 2 quarters · filed 2016-02-26 | $47.00K derived: sum of 3 quarters · filed 2016-02-26 | $55.00K 10-K · filed 2016-02-26 |
| 2013-09-30 | $13.00K 10-Q · filed 2014-11-07 | $18.00K derived: sum of 2 quarters · filed 2014-11-07 | $26.00K 10-Q · filed 2014-11-07 | $34.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $5.00K 10-Q · filed 2014-08-07 | $13.00K 10-Q · filed 2014-08-07 | $21.00K derived: sum of 3 quarters · filed 2015-02-24 | $34.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $8.00K 10-Q · filed 2014-05-09 | $16.00K derived: sum of 2 quarters · filed 2015-02-24 | $29.00K derived: sum of 3 quarters · filed 2015-02-24 | $51.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $21.00K derived: sum of 2 quarters · filed 2015-02-24 | $43.00K derived: sum of 3 quarters · filed 2015-02-24 | $69.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $13.00K 10-Q · filed 2013-11-07 | $35.00K derived: sum of 2 quarters · filed 2013-11-07 | $61.00K 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $22.00K 10-Q · filed 2013-09-05 | $48.00K 10-Q · filed 2013-09-05 | ||
| 2011-12-31 | $132.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |